Dr. Adam Zysk has >15 years of research experience in academic and clinical settings. He also led engineering development efforts and significant clinical studies of these technologies and plans to continue working to lead multi-disciplinary teams of physicians and engineers to pursue improvements in patient care. Additionally, Dr. Zysk is well-versed in Class II and III medical device regulatory submissions to the FDA. Dr. Zysk has also been a PI of multiple NIH-funded projects. He earned an MS and Ph.D. in Electrical and Computer Engineering from the University of Illinois at Urbana–Champaign and a BS in Electrical Engineering from Purdue University.
Org chart
Teams
Offices
Rhaeos
1 followers
Rhaeos is a VC backed, clinical stage medical device company developing FlowSense, a platform technology and a noninvasive wireless, wearable skin patch that can assess and monitor fluid flow subdermally throughout the body. The company is initially targeting hydrocephalus, a life threatening condition caused by an abnormal accumulation of cerebrospinal fluid (CSF). Implantable shunts, the gold standard treatment, often fail, leading to multiple trips to the emergency room and repeat surgeries. There is no technology available today that can easily assess CSF flow in shunts wirelessly, bedside, and without capital equipment until now.
